Clinical trial
Minimally-Invasive Upper Extremity Approach Versus Lower Extremity Approach for Transcatheter Aortic Valve Implantation (TAVI) Accessory Access Sites; A Prospective, Multicenter, Investigator-Initiated, Randomized Clinical Trial
NCT05672823 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimally-Invasive Upper Extremity Approach Versus Lower Extremity Approach for Transcatheter Aortic Valve Implantation (TAVI) Accessory Access Sites; A Prospective, Multicenter, Investigator-Initiated, Randomized Clinical Trial
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 28, 2022
- Completion date
- December 15, 2023
- Enrollment
- 238 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.